St. Luke's University Health Network — Bethlehem, Pennsylvania

St. Luke's University Health Network is a clinical research site located in Bethlehem, Pennsylvania, United States 18015.

Crixeo Health Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.

St. Luke's University Health Network has participated in 52 clinical trials with 23 currently active.

Therapeutic areas: Cutaneous Squamous Cell Carcinoma, Basal Cell Carcinoma, Solid Tumor.

Sponsors: Regeneron Pharmaceuticals, Debiopharm International SA, Boston Scientific Corporation.

Sponsor Feasibility Report

Trust Score: 86/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for St. Luke's University Health Network?

St. Luke's University Health Network has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has St. Luke's University Health Network conducted?

St. Luke's University Health Network has 52 clinical trials on record, with 23 currently active. Their work covers Cutaneous Squamous Cell Carcinoma, Basal Cell Carcinoma, Solid Tumor.

Is St. Luke's University Health Network accredited by Crixeo Health?

St. Luke's University Health Network has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about St. Luke's University Health Network?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.